(TLX) Talanx - Ratings and Ratios
Insurance, Reinsurance, Life, Property, Casualty
Dividends
| Dividend Yield | 2.50% |
| Yield on Cost 5y | 10.44% |
| Yield CAGR 5y | 11.88% |
| Payout Consistency | 99.6% |
| Payout Ratio | 29.7% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 24.1% |
| Value at Risk 5%th | 36.6% |
| Relative Tail Risk | -7.80% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.02 |
| Alpha | 26.89 |
| CAGR/Max DD | 2.48 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.455 |
| Beta | 0.070 |
| Beta Downside | 0.182 |
| Drawdowns 3y | |
|---|---|
| Max DD | 15.96% |
| Mean DD | 4.21% |
| Median DD | 3.51% |
Description: TLX Talanx October 14, 2025
Talanx AG (XETRA: TLX) is a German-based insurer and reinsurer that operates globally across a broad spectrum of life, non-life and specialty lines, including motor, aviation, cyber, and parametric solutions, as well as bancassurance and asset-management activities.
Founded in 1903 and headquartered in Hanover, the group is a subsidiary of HDI Haftpflichtverband der Deutschen Industrie V.a.G. and is classified under the GICS “Multi-line Insurance” sub-industry.
Key financial indicators (2023, per the company’s annual report) show a combined ratio of 94.5% for the non-life segment, a net profit of €1.2 billion, and a Solvency II ratio of 197%, indicating strong capital adequacy. The return on equity (ROE) stood at roughly 11%, aligning with the European insurance sector average.
Sector drivers that materially affect Talanx’s outlook include persistently low interest-rate environments that compress investment yields, heightened climate-related loss exposure (especially in property lines), and accelerating digital transformation that is reshaping underwriting and claims processing.
Assumption: the KPI figures are taken from the 2023 audited results; any material changes in regulatory capital requirements or macro-economic conditions could materially alter these metrics.
For a deeper quantitative breakdown, the ValueRay platform offers a granular view of TLX’s valuation metrics and scenario analyses.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (2.35b TTM) > 0 and > 6% of Revenue (6% = 1.51b TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 0.43pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -1.19% (prev 7.31%; Δ -8.49pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 12.01b > Net Income 2.35b (YES >=105%, WARN >=100%) |
| Net Debt (3.62b) to EBITDA (4.60b) ratio: 0.79 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.80 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (258.2m) change vs 12m ago 0.24% (target <= -2.0% for YES) |
| Gross Margin 20.24% (prev -1.96%; Δ 22.20pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 14.08% (prev 16.78%; Δ -2.70pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.60 (EBITDA TTM 4.60b / Interest Expense TTM 280.0m) >= 6 (WARN >= 3) |
Altman Z'' 0.29
| (A) -0.00 = (Total Current Assets 1.22b - Total Current Liabilities 1.52b) / Total Assets 179.50b |
| (B) 0.06 = Retained Earnings (Balance) 10.35b / Total Assets 179.50b |
| (C) 0.01 = EBIT TTM 1.29b / Avg Total Assets 179.20b |
| (D) 0.06 = Book Value of Equity 9.98b / Total Liabilities 159.90b |
| Total Rating: 0.29 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 62.29
| 1. Piotroski 5.50pt |
| 2. FCF Yield -9.75% |
| 3. FCF Margin 33.42% |
| 4. Debt/Equity 0.70 |
| 5. Debt/Ebitda 0.79 |
| 6. ROIC - WACC (= 0.75)% |
| 7. RoE 19.37% |
| 8. Rev. Trend -24.30% |
| 9. EPS Trend 82.57% |
What is the price of TLX shares?
Over the past week, the price has changed by -2.53%, over one month by +2.18%, over three months by -3.14% and over the past year by +31.92%.
Is TLX a buy, sell or hold?
What are the forecasts/targets for the TLX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 110.2 | 2.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 149.6 | 38.6% |
TLX Fundamental Data Overview December 08, 2025
Market Cap EUR = 27.94b (27.94b EUR * 1.0 EUR.EUR)
P/E Trailing = 11.9032
P/E Forward = 10.8696
P/S = 0.6625
P/B = 2.2
P/EG = 0.8913
Beta = 0.427
Revenue TTM = 25.23b EUR
EBIT TTM = 1.29b EUR
EBITDA TTM = 4.60b EUR
Long Term Debt = 8.37b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 293.0m EUR (from shortTermDebt, last fiscal year)
Debt = 8.90b EUR (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 3.62b EUR (from netDebt column, last fiscal year)
Enterprise Value = -86.50b EUR (27.94b + Debt 8.90b - CCE 123.34b)
Interest Coverage Ratio = 4.60 (Ebit TTM 1.29b / Interest Expense TTM 280.0m)
FCF Yield = -9.75% (FCF TTM 8.43b / Enterprise Value -86.50b)
FCF Margin = 33.42% (FCF TTM 8.43b / Revenue TTM 25.23b)
Net Margin = 9.31% (Net Income TTM 2.35b / Revenue TTM 25.23b)
Gross Margin = 20.24% ((Revenue TTM 25.23b - Cost of Revenue TTM 20.12b) / Revenue TTM)
Gross Margin QoQ = 2.98% (prev -656.4%)
Tobins Q-Ratio = -0.48 (set to none) (Enterprise Value -86.50b / Total Assets 179.50b)
Interest Expense / Debt = 0.04% (Interest Expense 4.00m / Debt 8.90b)
Taxrate = 30.72% (239.0m / 778.0m)
NOPAT = 892.3m (EBIT 1.29b * (1 - 30.72%))
Current Ratio = 0.80 (Total Current Assets 1.22b / Total Current Liabilities 1.52b)
Debt / Equity = 0.70 (Debt 8.90b / totalStockholderEquity, last quarter 12.70b)
Debt / EBITDA = 0.79 (Net Debt 3.62b / EBITDA 4.60b)
Debt / FCF = 0.43 (Net Debt 3.62b / FCF TTM 8.43b)
Total Stockholder Equity = 12.13b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.31% (Net Income 2.35b / Total Assets 179.50b)
RoE = 19.37% (Net Income TTM 2.35b / Total Stockholder Equity 12.13b)
RoCE = 6.28% (EBIT 1.29b / Capital Employed (Equity 12.13b + L.T.Debt 8.37b))
RoIC = 5.52% (NOPAT 892.3m / Invested Capital 16.18b)
WACC = 4.76% (E(27.94b)/V(36.84b) * Re(6.27%) + D(8.90b)/V(36.84b) * Rd(0.04%) * (1-Tc(0.31)))
Discount Rate = 6.27% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 77.89% ; FCFE base≈8.11b ; Y1≈7.90b ; Y5≈7.95b
Fair Price DCF = 547.1 (DCF Value 141.27b / Shares Outstanding 258.2m; 5y FCF grow -3.72% → 3.0% )
EPS Correlation: 82.57 | EPS CAGR: 20.42% | SUE: -1.10 | # QB: 0
Revenue Correlation: -24.30 | Revenue CAGR: 23.47% | SUE: 0.93 | # QB: 1
EPS next Year (2026-12-31): EPS=10.31 | Chg30d=+0.790 | Revisions Net=+4 | Growth EPS=+13.4% | Growth Revenue=+4.9%